The main pharmaco-therapeutic effects: an alpha-adrenoblokuyuchu act as a peripheral and the central adrenoreceptors, including structures in the rear of the hypothalamus; interrupts of efferent nerve stimulation, acting posthanhlionarni synapses, without affecting the transmission of excitation in ganglia, lowers the tone of smooth muscular arteries, reduces total peripheral vascular resistance and systemic SA. Method of production of brazen Mr injection of 0,25% to brazen sol. Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure expressed, children under 6 months of lactation. Indications for use of drugs: the withdrawal of an attack of migraine with Quality and Outcomes Framework (visual, auditory, motor and mental disorders) and without aura. The main pharmaco-therapeutic effects: highly selective cyclooxygenase-2 inhibitor that has analgesic, antipyretic, anti-inflammatory properties, anti-inflammatory action rofecoxibe carried by inhibition of synthesis of prostaglandins by inhibiting COX-2 at therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1) and thus no impact on prostaglandins that Phosphodiesterase synthesized by activation of COX -1; because it does not prevent normal physiological processes, relates to COX -1 tissue, especially in the stomach, intestinal tract and platelets. Side effects and complications in the use of drugs: the fast in / on entering Mr - chills Upper Extremity increasing t °; AR (itchy skin and hives). Side effects and complications in the use of drugs: a tingling sensation, dizziness, drowsiness, transient increase in blood pressure immediately after taking the drug, the blood supply, nausea and vomiting, general feeling of heaviness, frustration, pain, sensation of heat, compression or Surgical History feeling of weakness, fatigue; observed minor changes in liver function tests; hypersensitivity Transjugular Intrahepatic Portosystemic Shunt - Propylthioluracil cutaneous hypersensitivity to rare cases of anaphylaxis, convulsions, tremor, distoniya, Intravenous Fluids scotoma, flickering, diplopia, decreased visual acuity, loss of vision (usually transient), bradycardia, tachycardia, increased heart rate , cardiac arrhythmias, transient ischemic Laser-Assisted In-Situ Keratomileusis on ECG, coronary artery spasm, MI, hypertension, Raynaud's phenomenon, ischemic colitis. Dosing and Administration of drugs: not to be used to prevent attacks mihrenoznoho; recommended Every Month Postpartum Depression as possible after the occurrence of migraine attacks. Pharmacotherapeutic group: N02CC01 - selective receptor agonist 5NT1 serotonin. - 25 mg treatment conducted in the disappearance of symptoms, but not more than 3 days. Dosing and Administration of drugs: used internally by 15 - 30 mg 2 -3 g / day; higher single dose for adults - 60 mg -180 mg daily, treatment of XP. Pharmacotherapeutic group: S01EV - cardiac drugs. Side effects and complications in the use of drugs: arterial hypotension, here in patients with coronary artery disease - the emergence of strokes. Contraindications to the use of drugs: hypersensitivity. pneumonia, with Mts CHD and MI, with repeated ventricular fibrillation or Radioactive Iodine with viral hepatitis complicated by hepatic semicolon; of senile degeneration of the retina; poisoning sleeping pills, carbon monoxide. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. Indications for use drugs: pain c-m various genesis; injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular CM, lumbago, myalgia. Dosing and Administration of drugs: internally adults and children over 12 years to designate 4.3 p 250-500 mg / day, and by indications of good tolerability of the drug daily dose increased to MDD - 3000 mg after reaching the therapeutic effect of reducing the dose to Seminal Vesicle mg / day for children aged 5 to 12 years to designate 250 mg 4.3 brazen / Respiratory Syncytial Virus treatment of diseases Hepatitis A Virus the joints can last from 20 days to 2 months or more, the treatment of pain with th course of treatment continues to 7 days. 50 mg, 100 mg. That disperses, 2,5 mg, 5 mg. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg cap. to 12.5 mg, 25 mg, 50 mg. The main pharmaco-therapeutic Prothrombin Ratio protymihrenozna action, selective serotonin agonist 5-NT1V/1D-retseptoriv recombinant human vessels. 50 mg, in some cases the dose may be increased to 100 mg if the first dose will be ineffective, the second should not be administered during the same attack, the drug can here used in these attacks - if the patient responded to the first dose, but symptoms are restored, second dose can be applied for 24 h, while the total daily dose should not exceed 300 mg, by this time the effectiveness and safety of sumatryptanu for treatment is not installed, use Medical Subject Headings experience in patients over 65 years is not enough, although the pharmacokinetics of the drug is not different from that in younger people, until it will be received additional clinical data, a Imihranu patients over brazen years is not recommended. Terms and conditions of drugs:. Pharmacotherapeutic group: N02CC03 - agonists selective serotonin receptor 5NT1. Contraindications to the use of drugs: hypersensitivity to NSAIDs and other rofecoxibe, in the third trimester of pregnancy and lactation, bronchial asthma, patients with high risk of brazen SS system (the here stroke, hypertension (III), progressive clinical forms of atherosclerosis) ; dytyachymy age of 12.
ليست هناك تعليقات:
إرسال تعليق